OPEN END TURBO PUT WARRANT - ASTRAZENECA ADR | Market Closed - Boerse Frankfurt Warrants 17:19:19 03/07/2024 BST | ||
| 3.81 EUR | -0.26% |
|
| Current month | +3.53% | ||
| 1 month | +7.02% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
More news
| Date | Price | Change |
|---|---|---|
| 03/07/24 | 3.81 | -0.26% |
| 02/07/24 | 3.82 | +2.41% |
| 01/07/24 | 3.73 | +1.36% |
| 28/06/24 | 3.68 | -0.27% |
| 27/06/24 | 3.69 | +2.50% |
Real-time Boerse Frankfurt Warrants
Last update July 03, 2024 at 05:19 pm
More quotesStatic data
| Product type | Knock-Out sin Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ASTRAZENECA PLC |
| Issuer | UBS |
| WKN | UM516K |
| ISIN | DE000UM516K5 |
| Date issued | 23/05/2024 |
| Strike | 117.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.5 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.87 € |
|---|---|
| Lowest since issue | 3.38 € |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
153.4
USD
Average target price
174.6
USD
Spread / Average Target
+13.78%
- Stock Market
- Certificates
- Certificat
